(Q87419417)
Statements
Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: a randomized, open-label, phase IIb, 5-year study in Indian patients (English)
B K M Reddy
V Lokesh
M S Vidyasagar
K Shenoy
K G Babu
A Shenoy
T Naveen
R Bonanthaya
Nanjundappa
P P Bapsy
Loknatha
Jayarama Shetty
Krishna Prasad